162 results match your criteria: "Kouseiren Takaoka Hospital.[Affiliation]"

combined with L858R mutation reduced afatinib sensitivity and associated to early recurrence in lung cancer.

Transl Lung Cancer Res

November 2024

Department of Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University, Kanazawa, Japan.

Background: The third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is widely used as a first-line treatment for -mutated non-small cell lung cancer (NSCLC). However, there is no established treatment for osimertinib resistance, so second-generation afatinib is an alternative treatment option. The purpose of this study was to elucidate gene alterations associated with afatinib efficacy and resistance by analyzing cell-free DNA (cfDNA) obtained from patients with -mutated NSCLC.

View Article and Find Full Text PDF

Mandible Reconstruction With Custom-Made Plates in Medication-Related Osteonecrosis of the Jaw-A Case Series.

Case Rep Dent

October 2024

Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kanazawa Medical University, 1-1 Daigaku, Uchinada, Kahoku, Ishikawa 920-0293, Japan.

: Restoration of the mandibular region after segmental resection surgery is crucial for masticatory function and facial aesthetics. The precision of three-dimensional printers has advanced in recent years, enabling the development of fully customized reconstruction plates. In recent years, three-dimensional printing technology has been applied in the field of dental and oral surgery.

View Article and Find Full Text PDF

Postoperative decrease in serum albumin as predictor of early acute periprosthetic infection after total knee arthroplasty.

J Orthop Surg Res

October 2024

Graduate School of Medical and Dental Sciences, Niigata University Crisis Management Office, Niigata University Hospital, Niigata University, 1 Asahimachi Dori Niigata, Niigata, 951-8520, Japan.

Article Synopsis
  • The study investigates the relationship between serum albumin (SA) levels and the risk of early postoperative infections in patients undergoing total knee arthroplasty (TKA), particularly focusing on those with hypoalbuminemia (SA < 3.5 g/dL).
  • Data from 490 TKAs were analyzed, and while five patients experienced early infections needing surgery, there were no significant differences in SA levels or related parameters between the infected and non-infected groups.
  • The findings indicate that patients who developed infections had a higher reduction in SA levels around the time of their surgery but no clear link was established between SA levels and the occurrence of infections, suggesting further research is needed on the SA threshold of 3
View Article and Find Full Text PDF

The dynamics of perioperative serum albumin before and after total knee arthroplasty.

J Orthop

December 2024

Niigata University Crisis Management Office, Niigata University Hospital, Niigata University Graduate School of Medical and Dental Sciences, 1 Asahimachi Dori Niigata, Niigata, 951-8520, Japan.

Background: Previous studies have evaluated preoperative serum albumin (SA) for predicting postoperative complications of total knee arthroplasty (TKA). This study aimed to investigate the dynamics of perioperative SA and changes in SA (ΔSA) and identify any influential patient or surgical factors.

Methods: In total, 381 patients (483 knees) undergoing primary TKA were recruited.

View Article and Find Full Text PDF

Background: Vascular graft infection is a very complex disease. Although complete excision of the infected grafts with extra-anatomic bypass or in situ reconstruction is a general treatment strategy, some concerns including reinfection in the new graft remain.

Case Report: An 88 year-old man presented to the hospital with abdominal swelling and bleeding.

View Article and Find Full Text PDF
Article Synopsis
  • * A retrospective study from December 2021 to June 2023 analyzed 106 AGC patients, focusing on those with severe peritoneal metastasis who received nivolumab plus mFOLFOX6, finding that 19.8% of patients had severe cases.
  • * Results showed a median progression-free survival of 7.4 months and median overall survival of 10.7 months, with notable improvements in symptoms for a number of patients; however, some experienced significant
View Article and Find Full Text PDF

: Cardiovascular disease (CVD) is a major risk factor for mortality in patients with osteoarthritis, and such comorbidities increase the risk of postoperative complications following total knee arthroplasty (TKA). Arteriosclerosis plays a major role in hemodynamic dysfunction and CVD; however, the postoperative changes in arteriosclerosis following TKA have not been evaluated. Therefore, we assessed the postoperative changes in arteriosclerosis using the cardio-ankle vascular index (CAVI) in patients undergoing TKA, and its relationships with preoperative patient characteristics.

View Article and Find Full Text PDF

Background: Staying at home during the dying process is important for many patients; and palliative care units (PCUs) can help facilitate home death. This study compared patient survival between those who were discharged to home from a palliative care unit and those who were not, and aimed to identify the factors associated with home death after the discharge.

Methods: This retrospective cohort study used a database of patients admitted to a palliative care unit at Kouseiren Takaoka Hospital in Japan.

View Article and Find Full Text PDF

Background: The factors that predict the clinical response to ramucirumab plus docetaxel (RD) after first-line chemoimmunotherapy are unresolved. We explored whether the therapeutic efficacy of prior chemoimmunotherapy could predict the outcome of RD as sequential therapy in patients with advanced non-small cell lung cancer (NSCLC).

Methods: Our study comprised 288 patients with advanced NSCLC who received RD as the second-line treatment after first-line chemoimmunotherapy at 62 Japanese institutions.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICIs) show varying effectiveness depending on the metastatic site in gastric cancer (GC), influencing patient survival outcomes.
  • In a study of 148 GC patients treated with ICIs, those with non-systemic progression lived significantly longer than those with systemic progression, indicating different responses based on tumor growth patterns.
  • Liver metastasis was found to be particularly detrimental, correlating with lower CD8+ T-cell density and worse survival, suggesting that it may predict systemic progression in GC patients receiving ICIs.
View Article and Find Full Text PDF

Introduction: Atezolizumab plus bevacizumab (Atez/Bev) is a standard treatment for unresectable hepatocellular carcinoma (HCC) due to its good antitumor and survival prolongation effects. Post-progression survival (PPS) has been reported to be a great contributor in the treatment with tyrosine kinase inhibitors for unresectable HCC. This study aimed to clarify the significance of progression-free survival (PFS) or PPS of Atez/Bev treatment for HCC.

View Article and Find Full Text PDF

Purpose: Cardiovascular disease (CVD) is a major risk factor for mortality in patients with osteoarthritis, and comorbidities increase postoperative complications after total knee arthroplasty (TKA). Arteriosclerosis plays a main role in hemodynamic dysfunction and CVD; however, arteriosclerosis has not been preoperatively evaluated before TKA using the cardio-ankle vascular index (CAVI). In this study, we evaluated the degree of preoperative arteriosclerosis using the CAVI in patients undergoing TKA, as well as its correlations with several preoperative patient factors.

View Article and Find Full Text PDF
Article Synopsis
  • * A 58-year-old Japanese man, diagnosed with MCTD 15 years prior, experienced new symptoms that indicated a progression to SLE, including positive anti-dsDNA antibody and a kidney biopsy showing lupus nephritis class IV.
  • * Changing his treatment for lupus nephritis led to remission, highlighting the importance of monitoring MCTD patients for signs of evolving into other connective tissue diseases over time.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to determine if indocyanine green fluorescence imaging (ICG-FI) could lower the rate of anastomotic leakage in patients undergoing minimally invasive rectal cancer surgery.
  • Conducted across 41 hospitals in Japan, 850 patients were randomized into two groups: one receiving ICG-FI for blood flow evaluation and the other not receiving it, with outcomes measured for leakage rates.
  • The results showed that the ICG+ group had a significantly lower anastomotic leakage rate (7.6%) compared to the ICG- group (11.8%), indicating that while ICG-FI did help reduce leakage, it was not superior to traditional methods.
View Article and Find Full Text PDF

Purpose: This study sought to clarify the positional relationship between the Achilles tendon and sural nerve using ultrasound.

Methods: We studied 176 legs in 88 healthy volunteers. The positional relationship between the Achilles tendon and sural nerve at heights of 2, 4, 6, 8, 10, and 12 cm proximal from the calcaneus' proximal margin was investigated by distance and depth.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effectiveness of olanzapine added to standard antiemetic therapy for patients undergoing cisplatin-based chemotherapy, particularly focusing on those with high risk for chemotherapy-induced nausea and vomiting (CINV).
  • This analysis draws from the J-FORCE trial, which included diverse participants aged 20 to 75 across multiple hospitals in Japan, examining various factors like age and history of motion sickness to gauge the drug's added benefits.
  • Key outcomes of the trial measure complete response (no vomiting or need for rescue medication) in the delayed phase after chemotherapy, along with several secondary outcomes related to control over CINV based on individual risk factors.
View Article and Find Full Text PDF

Background: Staying at a preferred place, principally at home, is of great value for dying patients, and palliative care units (PCUs) have an important role in providing adequate support so that patients can be discharged and go home. We attempted to create and validate a scoring tool to predict whether a cancer patient admitted to a PCU will be discharged home.

Methods: All 369 cancer patients admitted to the PCU of a 533-bed general hospital in Japan from October 2016 to October 2019 were enrolled.

View Article and Find Full Text PDF

Genetic testing for inherited arrhythmias and discriminating pathogenic or benign variants from variants of unknown significance (VUS) is essential for gene-based medicine. KCNQ1 is a causative gene of type 1 long QT syndrome (LQTS), and approximately 30% of the variants found in type 1 LQTS are classified as VUS. We studied the role of zebrafish cardiac arrhythmia model in determining the clinical significance of KCNQ1 variants.

View Article and Find Full Text PDF

Introduction: This study aimed to identify factors associated with adjacent vertebral fracture (AVF) incidence after balloon kyphoplasty (BKP).

Methods: To perform the analyses, 133 vertebrae of 128 patients who underwent BKP for osteoporotic vertebral compression fracture were retrospectively investigated. According to the presence of AVF throughout a 1-year period following BKP, patients were divided into AVF (n = 22) and non-AVF (n = 111) groups.

View Article and Find Full Text PDF

Bevacizumab and eribulin are novel agents for the treatment of HER2-negative metastatic breast cancer (MBC); however, the choice between bevacizumab and eribulin for MBC can be difficult. The present study aimed to compare two treatment strategies, eribulin followed by bevacizumab and paclitaxel (BEV + PTX) versus BEV + PTX followed by eribulin, to determine whether the order of administration affects the outcome of MBC in the real world. A total of 180 patients who started BEV + PTX and eribulin treatment for HER2-negative MBC from August 2011 to June 2018 were selected.

View Article and Find Full Text PDF

Infected coronary artery aneurysm (ICAA) is a rare but fatal disease. We describe a case of rapid formation of ICAA with fracture of an intracoronary stent observed on coronary angiography and cardiac computed tomography. Surgery with resection of the aneurysm and coronary artery bypass grafting was performed successfully.

View Article and Find Full Text PDF

Background: The standard of care for unresectable, locally advanced non-small-cell lung cancer (LA-NSCLC) is chemoradiotherapy (CRT) followed by durvalumab, based on the PACIFIC study. Although multiple Japanese phase II studies have shown high efficacy and tolerability of CRT with cisplatin plus S-1 (SP), no prospective study using durvalumab after SP-based CRT has been reported.

Objectives: We conducted a multicenter phase II study of this approach, the interim analysis of which showed a high transition rate to durvalumab consolidation therapy.

View Article and Find Full Text PDF

A 55-year-old woman was suspected of having hilar lymph node enlargement on a routine examination of the chest computed tomography( CT) scan at our hospital. On further examination, thoracic contrast CT and bronchial arteriography showed prominent dilation and meandering of the right bronchial artery with an aneurysm which formed a fistula to the pulmonary artery A7 at its distal end. Diagnosed as racemose hemangioma of bronchial artery with pulmonary artery fistula, we performed a surgical resection by open thoracotomy on the second day following bronchial artery embolization( BAE).

View Article and Find Full Text PDF

Introduction: Pembrolizumab is a programmed death-ligand 1 inhibitor that was initially indicated for monotherapy in patients with advanced lung cancer. The Japanese Lung Cancer Society conducted an observational study on pembrolizumab using confirmative data obtained through postmarketing all-case surveillance (PMACS), which was performed by a pharmaceutical company under the Japanese law in 2017.

Methods: This multicenter observational study was conducted by the Japanese Lung Cancer Society using PMACS data with the newly created central registration system regarding patients with NSCLC who received pembrolizumab monotherapy between February 1, 2017 and June 30, 2017; a new database was created by adding the clinical information regarding prognosis for 3 years after therapy to the existing data collected by PMACS.

View Article and Find Full Text PDF